首页 › 基金 › Andera Partners › AGMB

Andera Partners 对 AGMB 的持仓历史

AGOMAB THERAPEUTICS NV · 医疗保健

Andera Partners 在 Q3 2026 的 13F 申报中披露持有 AGMB(AGOMAB THERAPEUTICS NV)1,538,702 股,市值约 US$17.1M,约占其申报组合的 9.72%,在其申报持仓中市值排名第 4 位。 Andera Partners 最近 3 个申报季度中有 3 个季度披露了 AGMB 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)1.54M 股
申报持仓市值$17.08M
组合权重9.72%
首次申报Q1 2026
最近变动持有
更新于2026-10-17

最后更新: 2026-10-17 · 来源: SEC EDGAR Form 13F-HR

Andera Partners 对 AGMB 的持仓演变

Andera Partners 于 Q1 2026 首次披露 AGMB 持仓:1,538,702 股(约 US$16.1M)。 该持仓在 Q2 2026 达到峰值 1,538,702 股,市值约 US$20.0M。 在 3 次申报中,Andera Partners 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 1,538,702 股、市值约 US$17.1M。

逐季持仓明细

季度股数金额变化
Q1 2026 1.54M $16.14M 新进
Q2 2026 1.54M $19.97M 持有
Q3 2026 1.54M $17.08M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 AGMB 与 13F 数据

AGMB(AGOMAB THERAPEUTICS NV)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 AGMB,申报仓位最大的包括:EQT Fund Management S.a r.l. (US$66.7M), Sanofi (US$36.1M), Redmile Group, LLC (US$35.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 AGMB 的基金

查看 AGMB 的全部基金持有人 →

常见问题

How long has Andera Partners held AGMB?

Andera Partners has disclosed AGMB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Andera Partners's current position in AGMB?

As of Q3 2026, Andera Partners holds 1.54M shares of AGMB (AGOMAB THERAPEUTICS NV), valued at $17.08M, representing 9.72% of its reported portfolio and ranking #4.

Has Andera Partners been buying or selling AGMB?

In the latest 13F filing (Q3 2026), Andera Partners held unchanged its position in AGMB. The position peaked in Q2 2026 at 1.54M shares.

Which other funds hold AGMB?

Other major institutional holders of AGMB include EQT Fund Management S.a r.l., Sanofi, Redmile Group, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.